Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01755247 · ClinicalTrials.gov registry record · Phase 1
A Phase 1, 3 Day Study of Safety and Tolerability of NVN1000 Topical Gel in Healthy Volunteers
A Phase 1 study, sponsored by Novan.
- Completed
- Registry status
- Phase 1
- Development phase
- 15
- Enrollment target
NCT01755247 is a Phase 1 study that has completed, run by Novan. The registered enrollment target is 15 participants.
The verdict
NCT01755247, a Phase 1 study, has completed, sponsored by Novan.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 15 participants
- Enrollment target
Study Summary
A Phase I, Single-Center, Open-Label, Randomized, Parallel Group, 3 Day Study Evaluating the Safety and Cutaneous Tolerability of NVN1000 Topical Gel in Healthy Volunteers
Interventions
- DRUG 8% NVN1000 Topical Gel
- DRUG Topical Gel Vehicle
- DRUG 8% NVN1000 Topical Gel and moisturizer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2012-11 |
| Est. Completion | 2012-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01755247
The ClinicalTrials.gov registry entry for NCT01755247 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Novan, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which 8% NVN1000 Topical Gel is the first listed.
NCT01755247 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01755247 about?
NCT01755247 is a clinical study titled "A Phase 1, 3 Day Study of Safety and Tolerability of NVN1000 Topical Gel in Healthy Volunteers". A Phase I, Single-Center, Open-Label, Randomized, Parallel Group, 3 Day Study Evaluating the Safety and Cutaneous Tolerability of NVN1000 Topical Gel in Healthy Volunteers
What is the current status of trial NCT01755247?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 15 participants. The study started on 2012-11. Estimated completion is 2012-12.
What interventions are being tested in trial NCT01755247?
The interventions under investigation include: 8% NVN1000 Topical Gel (DRUG), Topical Gel Vehicle (DRUG), 8% NVN1000 Topical Gel and moisturizer (DRUG).
Who is sponsoring clinical trial NCT01755247?
This trial is sponsored by Novan, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.